sd8566131 luna flow bulk kt a2 2g henry schein new zealand represents a streamlined procurement option for dental practices seeking trusted restorative materials. This specific unit combines a flowable composite with reliable Henry Schein distribution in the New Zealand market.
For teams managing inventory, understanding product specifications, lead times, and compliance details helps ensure uninterrupted clinical workflows. The following breakdown translates complex sourcing details into actionable information for dental buyers and practice managers.
| Product Code | Description | Key Specification | Availability in New Zealand |
|---|---|---|---|
| sd8566131 | Luna Flow Bulk | Flowable Composite, 2g Syringe | Distributed via Henry Schein NZ |
| Material Type | Composite Resin | Flowable Consistency for Adaptation | Imported, Certified |
| Syringe Capacity | 2 Grams | Single Use, Light-Cured | Henry Schein Stocked Item |
| Regulatory Status | CE Marked, TGA Compliant | Meets NZ Medsafe Requirements | Available Through Henry Schein New Zealand |
Clinical Handling and Technique for Luna Flow
Material Handling Tips
Maintaining optimal handling conditions for sd8566131 luna flow bulk kt a2 ensures predictable performance. Use consistent syringe preparation, avoid excessive rolling, and monitor curing light intensity to achieve reliable results.
Operational Protocols
Dental practices should establish clear protocols for mixing, placement, and curing when working with flowable composites. Standardized workflows reduce waste and support efficient chairside execution for routine and complex cases.
Product Specifications and Performance
Physical and Mechanical Properties
Luna flow bulk kt a2 2g offers specified viscosity and filler characteristics designed for adaptation in cavity preparations. Understanding these properties helps clinicians match material behavior to restorative requirements.
Compatibility with Adhesive Systems
Confirm compatibility with the adhesive system used in practice to prevent bonding issues. Proper surface treatment and sequencing enhance long-term durability of restorations placed with this flowable composite.
Procurement and Supply Chain Considerations
Ordering and Inventory Management
Henry Schein New Zealand provides structured ordering processes and predictable lead times for dental professionals. Reviewing purchase history and usage patterns supports accurate reordering and minimizes stockouts.
Regulatory and Compliance Information
Products supplied through Henry Schein in New Zealand meet local regulatory standards, including Medsafe requirements. Practitioners should verify documentation and storage conditions to remain compliant with clinical and legal obligations.
Guidance for Clinical Integration and Practice Workflow
- Review product data sheets and technical specifications for handling details.
- Establish ordering cadence with Henry Schein New Zealand to maintain inventory levels.
- Train clinical teams on material-specific placement and curing techniques.
- Document usage and outcomes to inform future procurement and clinical decisions.
FAQ
Reader questions
Is sd8566131 luna flow bulk kt a2 2g suitable for direct posterior restorations?
Yes, this flowable composite is designed for indications where adaptation and sealing are important, though clinicians should evaluate mechanical requirements and choose materials based on cavity design and load.
How quickly can I expect delivery when ordering through Henry Schein New Zealand?
Delivery timelines vary by location and stock levels, but Henry Schein New Zealand typically provides standard lead times, with options for expedited service where available.
Do I need any special curing equipment for this material?
Standard dental curing lights are suitable, provided they meet the recommended intensity and wavelength specifications. Verifying curing protocols ensures complete polymerization and optimal clinical performance.
Can this product be used in pediatric cases?
Yes, it is suitable for pediatric applications where flowable characteristics aid in adaptation and moisture control, while biocompatibility and regulatory approvals support safe use in younger patients.